卖什么
活细胞运输技术。
商业模式拆解
买家：谁掌握预算？
未核实Procurement/lab heads at biotech, pharma, CGT manufacturers, hospitals and IVF clinics.
触发点：什么让他们现在购买？
Cryopreservation damages cell viability; live-cell shipment claimed to deliver 2.5x more functional NK cells after recovery than cryopreserved transport.
工作流：什么输入变成什么输出？
Pack cells in a Cellbox Go (short/mid distance) or Shipper (up to 48h runtime) incubator preset to temperature and CO2, ship with data logging, receive cells under physiological conditions with no freeze-thaw.
经济账：省了什么，怎么收费？
Hardware sales (Cellbox Go/Shipper, new Core Edition) plus logistics services: fleet management and shipment services for live-cell logistics. No prices shown.
渠道：怎么接触到客户？
Direct inquiry-led ("Get in touch"); product pages per Go Ground/Flight and Shipper Ground/Flight.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-03-06 | — | €3.5M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.